How PX1 Tests Every SLU-PP-332 Lot (HPLC, MS, Endotoxin)
PX1 Research enforces stringent analytical validation across every production lot of SLU-PP-332 to ensure absolute structural identity, chemical purity, and biological safety. Explore our comprehensive multi-tier testing stack—including reverse-phase HPLC, electrospray mass spectrometry, and LAL endotoxin assays—designed to provide research institutions with verified, high-purity compounds for in vitro and preclinical investigation.
Quick answer
PX1 Research enforces stringent analytical validation across every production lot of SLU-PP-332 to ensure absolute structural identity, chemical purity, and biological safety. Explore our comprehensive multi-tier testing stack—including reverse-phase HPLC, electrospray mass spectrometry, and LAL endotoxin assays—designed to provide research institutions with verified, high-purity compounds for in vitro and preclinical investigation.
Key takeaways
- In contemporary metabolic and bioenergetic investigation, compound integrity dictates experimental reproducibility.
- Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) serves as the primary tool for quantifying chemical purity and identifying hydrophobic organic impurities in SLU-PP-332 lots.
- While HPLC confirms chemical homogeneity, Mass Spectrometry (MS) provides unambiguous proof of molecular identity.
- [HPLC purity](/research-peptides/how-to-verify-peptide-purity-before-buying) measures relative clean-up, but it does not measure the actual concentration of active target compound per unit mass of lyophilized powder.
The Necessity of Stringent Quality Control for SLU-PP-332
In contemporary metabolic and bioenergetic investigation, compound integrity dictates experimental reproducibility. SLU-PP-332, a synthetic estrogen-related receptor (ERR) agonist, has emerged as a key molecule in preclinical models evaluating mitochondrial biogenesis, oxidative phosphorylation, and cellular energy homeostasis. However, minor chemical impurities, residual synthesis reagents, or bioburden contamination can significantly alter cellular assays, leading to skewed enzymatic kinetics or confounding cytotoxic responses.
To prevent analytical artifacts, PX1 Research implements an uncompromising quality assurance framework. Every batch of slu-pp-332 third party tested material undergoes rigorous multi-modal analysis in independent, ISO 17025-accredited analytical laboratories prior to distribution. By establishing standardized testing protocols across our complete catalog of all-peptides and small molecules, PX1 ensures that researchers receive compounds conforming to exact molecular standards.
Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC)
Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) serves as the primary tool for quantifying chemical purity and identifying hydrophobic organic impurities in SLU-PP-332 lots. Testing is conducted using advanced liquid chromatography systems equipped with diode-array detectors (DAD) operating across a 210–280 nm ultraviolet wavelength spectrum.
The analytical method utilizes a C18 hydrophobic stationary phase column subjected to a linear gradient elution of water and acetonitrile, modulated with 0.1% trifluoroacetic acid (TFA) as an ion-pairing agent. Purity is calculated using the chromatographic area percent method: the integrated area under the primary SLU-PP-332 peak is divided by the total area of all detected peaks. PX1 Research mandates that every release batch exhibit an RP-HPLC area purity of ≥98.0%, ensuring minimal background noise in sensitive cell culture or enzymatic assays.
Mass Spectrometry (MS) and Structural Identity Verification
While HPLC confirms chemical homogeneity, Mass Spectrometry (MS) provides unambiguous proof of molecular identity. For SLU-PP-332, high-resolution Electrospray Ionization Mass Spectrometry (ESI-MS) or Matrix-Assisted Laser Desorption/Ionization Time-of-Flight (MALDI-TOF) mass spectrometry is employed to determine exact mass-to-charge (m/z) ratios.
The resulting spectrum is evaluated against the theoretical monoisotopic mass of the SLU-PP-332 molecule. A lot is verified only when the observed molecular ion peak aligns precisely with the predicted theoretical mass (typically within a tolerance of ±0.5 Da for unit mass resolution, or <5 ppm for high-resolution MS). This step eliminates the risk of issuing structurally altered derivatives, incomplete synthesis products, or mislabeled chemical precursors.
Total Peptide and Organic Compound Content Quantification
HPLC purity measures relative clean-up, but it does not measure the actual concentration of active target compound per unit mass of lyophilized powder. Freeze-dried organic salts and peptides routinely retain residual moisture, counter-ions (such as acetate or TFA), and trace salts. Consequently, a vial containing 10 mg of bulk powder does not equate to 10 mg of pure active reagent.
PX1 performs total nitrogen analysis (via Elemental Analysis/CHNS) or Net Compound Content determination to quantify the exact mass percentage of active SLU-PP-332 within each batch. Knowing the net compound factor allows investigators utilizing our reconstitution-calculator to calibrate working concentrations accurately, preventing systemic dosage errors in cell-based assays.
Bacterial Endotoxin Testing via Limulus Amebocyte Lysate (LAL) Assay
Endotoxins—lipopolysaccharides (LPS) derived from the outer membrane of Gram-negative bacteria—are potent inflammatory pyrogens. In cell culture models, even trace endotoxin contamination can trigger toll-like receptor 4 (TLR4) signaling, masking or altering the metabolic mechanisms under investigation.
PX1 subjects all synthesized compounds to quantitative Kinetic Chromogenic Limulus Amebocyte Lysate (LAL) testing. Each lot of SLU-PP-332 must demonstrate endotoxin levels below 0.05 Endotoxin Units per milligram (EU/mg). This rigorous threshold ensures that observed bioenergetic or gene expression changes in preclinical assays are attributable solely to ERR activation rather than endotoxin-induced immune response.
Bioburden Determination and Sterility Assays
Beyond endotoxin quantification, physical bioburden testing is mandatory for all finished research materials. Sample aliquots from each batch are reconstituted in sterile water and incubated on tryptic soy agar (TSA) and sabouraud dextrose agar (SDA) media to monitor for aerobic bacteria, yeast, and mold growth over a 14-day incubation period.
Lots exhibiting any detectable colony-forming units (CFU) are immediately rejected and destroyed. This multi-day incubation protocol guarantees that compounds formatted for laboratory procedures, whether as raw powder or packaged research formats like SLU-PP-332 capsules 250mcg, remain sterile and biological-contaminant-free throughout their operational shelf life.
Retained Samples, Lot Stability, and Quality Records
Quality assurance extends beyond initial batch release. PX1 Research maintains a dedicated sample retention repository where representative aliquots from every production lot are stored under controlled environmental conditions (-20°C and -80°C cryogenic storage).
These retained samples undergo periodic stability re-testing at 6-month and 12-month intervals via RP-HPLC to establish degradation kinetics, stability profiles, and ideal storage parameters. Should an academic or industrial lab encounter unexpected experimental data, PX1 can re-analyze the exact retained lot to confirm ongoing stability and structural integrity.
How to Verify Your Batch: Matching COA to Vial Lot Numbers
Transparency requires seamless access to analytical data. Every vial and unit dispatched by PX1 Research features a unique, laser-printed lot number matching its precise synthesis run. Investigators can immediately inspect their lot's complete analytical records by visiting our centralized COA lookup database.
A valid Certificate of Analysis for SLU-PP-332 displays the specific HPLC chromatogram, MS spectral data, LAL endotoxin reading, pass/fail bioburden results, and testing dates signed by a qualified QC analytical chemist. Researchers are strongly encouraged to cross-reference lot numbers upon delivery to ensure full traceability prior to initiating reconstitution or assay prep.
Comparative Analysis: SLU-PP-332 and Related Metabolic Research Compounds
Within preclinical bioenergetic research, SLU-PP-332 is frequently evaluated alongside other synthetic modulators of cellular metabolism, such as Rev-ErbA agonists and mitochondrial-derived peptides. Understanding the analytical and structural differences across these classes is vital when designing comparative metabolic screens.
For instance, compounds like SR-9009 powder (a Rev-Erb agonist) and GW-501516 powder (a PPARδ agonist) target distinct transcription factor families, requiring different RP-HPLC mobile phase gradients due to varying lipophilicity profiles. Similarly, endogenous mitochondrial peptides like MOTS-c 5mg rely on peptide-specific mass spec fragment tracking to confirm primary sequence fidelity. PX1 maintains identical testing rigor—HPLC purity, MS identity, and LAL endotoxin screening—across all of these metabolic research tools.
PX1 Research Quality Assurance & Laboratory Supply Standards
PX1 Research operates as a trusted USA-based supplier dedicated exclusively to supporting laboratory research, academic institutions, and contract research organizations (CROs). All manufacturing and fill processes occur within GMP-compliant, ISO-certified facilities designed to eliminate cross-contamination.
By pairing rigorous USA manufacturing with third-party testing validation, PX1 offers unparalleled lot-to-lot consistency. Whether ordering standard quantities or setting up institutional procurement through our wholesale lab account portal, researchers receive fully validated compounds backed by rapid same-day shipping from our California and Arizona logistics hubs. Explore our comprehensive research library for technical guides and analytical documentation.
Frequently Asked Questions
Where can I find the Certificate of Analysis (COA) for my SLU-PP-332 lot?
You can view and download the batch-specific COA directly by entering the lot number printed on your vial label into the PX1 COA lookup portal at /coa.
What analytical techniques are used to verify SLU-PP-332 purity?
PX1 utilizes Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for area purity quantification and Electrospray Ionization Mass Spectrometry (ESI-MS) for molecular weight and structural identity confirmation.
What is the maximum endotoxin limit allowed for PX1 SLU-PP-332 lots?
Every lot of SLU-PP-332 must pass quantitative LAL testing showing endotoxin levels strictly below 0.05 EU/mg before release.
How should reconstituted SLU-PP-332 solutions be stored in the lab?
Reconstituted stock solutions should be aliquoted and stored at -20°C or -80°C to prevent hydrolysis and photo-degradation. Avoid repeated freeze-thaw cycles.
Why is net peptide content testing important alongside HPLC purity?
HPLC measures chemical purity relative to contaminants, but net content testing accounts for residual moisture and counter-ions, ensuring precise mass calculations during reagent preparation.
Are PX1 Research compounds intended for human administration?
No. All products sold by PX1 Research, including SLU-PP-332, are strictly for in vitro laboratory research and preclinical animal studies. They are not for human or veterinary use.
What facility standards are used in the production and testing of PX1 materials?
Materials are processed in GMP-compliant facilities and tested by independent, ISO 17025-accredited analytical laboratories.
How long are retained lot samples kept by PX1 Research?
Retained samples from every lot are stored in temperature-controlled cryogenic units for a minimum of 24 months to support ongoing stability testing and retrospective quality audits.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.